Concepedia

Tzu-Hsuan Huang

TH

Statistics

Publications

11

Citations

515

H-Index

10

Active since

2000

Affiliations

Pfizer (United States)(Current)

National Taiwan University

AbbVie (United States)

Karolinska Institutet

Centre international de recherche sur le cancer

Tzu-Hsuan Huang is an author at Pfizer (United States) specializing in oncology, life sciences, and cancer immunology.

Publications per year

2000–2023

11

Publications

11

Apo2L/TRAIL and the Death Receptor 5 Agonist Antibody AMG 655 Cooperate to Promote Receptor Clustering and Antitumor Activity

Jonathan D. Graves, Jennifer J. Kordich, Tzu-Hsuan Huang et al. · Cancer Cell · 2014 · 155 citations · Full text

Life Sciences, Oncology, Pharmacology +17

An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity

Yuanming Xu, Lucia Campos Carrascosa, Yik A. Yeung et al. · Cancer Immunology Research · 2021 · 98 citations · Full text

Life Sciences, Immunology, Oncology +17

Targeting IFN-α to B Cell Lymphoma by a Tumor-Specific Antibody Elicits Potent Antitumor Activities

Tzu-Hsuan Huang, Koteswara R. Chintalacharuvu, Sherie L. Morrison · The Journal of Immunology · 2007 · 50 citations · Full text

Life Sciences, Immunology, Oncology +11

Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation

Anders Mälarstig, Leo Dahl, Marios Dimitriou et al. · Nature Communications · 2023 · 50 citations · Full text

Medicine, Genetics, Oncology +17

Enhanced antitumor immunity by fusion of CTLA-4 to a self tumor antigen

Tzu-Hsuan Huang, Pin-Yi Wu, Chin-Nien Lee et al. · Blood · 2000 · 33 citations

Life Sciences, Immunology, Oncology +14

1–5 of 11